ArticleAllergy2022
Selenomethionine attenuates allergic effector responses in human primary mast cells.
Xiaoli Zhao, Bart R J Blokhuis, Frank A Redegeld, Iris Chang, Diane Dunham, Hongbing Chen, Kari Nadeau, Johan Garssen, Leon M J Knippels, Astrid Hogenkamp
Open access · hybridAbstract readLetter
In one paragraphArticle in Allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors at 3 institutions in 3 countries.
Xiaoli ZhaoState Key Laboratory of Food Science and Technology, Nanchang University, Jiangxi, China.
Bart R J BlokhuisDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
Frank A RedegeldDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
Iris ChangGlobal Centre of Excellence Immunology, Danone/Nutricia Research, Utrecht, The Netherlands.
Diane DunhamGlobal Centre of Excellence Immunology, Danone/Nutricia Research, Utrecht, The Netherlands.
Hongbing ChenState Key Laboratory of Food Science and Technology, Nanchang University, Jiangxi, China.ORCID 0000-0002-4845-383X Kari NadeauGlobal Centre of Excellence Immunology, Danone/Nutricia Research, Utrecht, The Netherlands.ORCID 0000-0002-2146-2955 Johan GarssenDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.ORCID 0000-0002-8678-9182 Leon M J KnippelsDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
Astrid HogenkampDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.ORCID 0000-0003-2051-9259 Utrecht University · NLDanone (Netherlands) · NLNanchang University · CN
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Food HypersensitivityMast CellsHumansSelenomethionineSelenomethioninefood allergyprimary human mast cellSelenomethioninesoy allergy
Identifiers
PMID35451124
PMCPMC9710852
OpenAlexW4224234241
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390